NEWS NEWS NEWS today We had great news !!! great news for CYGX and DNAG TODAY .
CytoGenix and the University of Texas Medical Branch at Galveston Sign Agreement for Preclinical Testing of synDNA(TM) H5N1 Avian Flu Vaccine Candidates Tuesday May 16, 5:05 pm ET
HOUSTON--(BUSINESS WIRE)--May 16, 2006--CytoGenix, Inc. (OTCBB:CYGX - News) has entered into a research agreement with the University of Texas Medical Branch at Galveston for preclinical animal studies of synDNA(TM) H5N1 vaccine. Dr. Slobodan Paessler, scientific director of the Animal Biosafety Laboratory and the Galveston National Laboratory Advanced Veterinary Services (GAVS) Core will be supervising the research. ADVERTISEMENT
CytoGenix scientists have developed a synthetic DNA vaccine against a known strain of H5N1 as a test bed for efficacy and safety studies. In preparation for a possible pandemic, the synDNA(TM) technology is designed to produce millions of doses of a DNA vaccine in a period of a few months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.